https://www.nature.com/articles/s41598-023-33024-2
0
0
MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference | Scientific Reports - Nature.com
4/28/23 at 11:39am
Organization
Nature.com
Authors
Details
50 words
Summarize
Health Scientific Reports - Nature.com Scientific Reports - MasitinibL MasitinibL masitinib 3CLpro anti-SARS-CoV-2 kinase preference
Scientific Reports - MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
Create an account or login to join the discussion